Published in J Immunol Methods on May 27, 1999
Bacillus Calmette-Guérin (BCG) complications associated with primary immunodeficiency diseases. J Infect (2012) 1.06
Disseminated Bacillus Calmette-Guérin lymphadenitis in a patient with gp91phox- chronic granulomatous disease 25 years after vaccination. Eur J Pediatr (2008) 0.80
Mycobacteria infect different cell types in the human lung and cause species dependent cellular changes in infected cells. BMC Pulm Med (2016) 0.77
Long-term follow-up and prognosis of chronic granulomatous disease in Yugoslavia: is there a role for early bone marrow transplantation? J Clin Immunol (2003) 0.75
X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat Genet (2001) 10.92
Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science (2000) 10.40
Interferon-gamma-receptor deficiency in an infant with fatal bacille Calmette-Guérin infection. N Engl J Med (1996) 5.36
Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency. Science (1998) 4.58
Severe mycobacterial and Salmonella infections in interleukin-12 receptor-deficient patients. Science (1998) 4.24
X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-kappaB signaling. Nat Genet (2001) 3.86
A human IFNGR1 small deletion hotspot associated with dominant susceptibility to mycobacterial infection. Nat Genet (1999) 3.12
Partial interferon-gamma receptor 1 deficiency in a child with tuberculoid bacillus Calmette-Guérin infection and a sibling with clinical tuberculosis. J Clin Invest (1997) 2.76
Evidence for inhibition of fusion of lysosomal and prelysosomal compartments with phagosomes in macrophages infected with pathogenic Mycobacterium avium. Infect Immun (1986) 2.71
IL-12 and IFN-gamma in host defense against mycobacteria and salmonella in mice and men. Curr Opin Immunol (1999) 2.69
Impairment of mycobacterial but not viral immunity by a germline human STAT1 mutation. Science (2001) 2.52
Novel human immunodeficiencies reveal the essential role of type-I cytokines in immunity to intracellular bacteria. Immunol Today (1998) 2.49
Inherited interleukin 12 deficiency in a child with bacille Calmette-Guérin and Salmonella enteritidis disseminated infection. J Clin Invest (1998) 2.30
Single-cell PCR analysis of TCR repertoires selected by antigen in vivo: a high magnitude CD8 response is comprised of very few clones. Immunity (1996) 2.27
Immunological conditions of children with BCG disseminated infection. Lancet (1995) 2.05
Treatment of the immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) by allogeneic bone marrow transplantation. N Engl J Med (2001) 2.05
Value of open lung biopsy in immunocompromised children. J Pediatr (2000) 1.96
Fatal disseminated Mycobacterium smegmatis infection in a child with inherited interferon gamma receptor deficiency. Clin Infect Dis (1997) 1.96
Host genetics of mycobacterial diseases in mice and men: forward genetic studies of BCG-osis and tuberculosis. Annu Rev Genomics Hum Genet (2007) 1.88
Early and prolonged intravenous immunoglobulin replacement therapy in childhood agammaglobulinemia: a retrospective survey of 31 patients. J Pediatr (1999) 1.73
The ClpC ATPase of Listeria monocytogenes is a general stress protein required for virulence and promoting early bacterial escape from the phagosome of macrophages. Mol Microbiol (1998) 1.61
Partial interferon-gamma receptor signaling chain deficiency in a patient with bacille Calmette-Guérin and Mycobacterium abscessus infection. J Infect Dis (2000) 1.58
Correlation of granuloma structure with clinical outcome defines two types of idiopathic disseminated BCG infection. J Pathol (1997) 1.47
Severe aplastic anemia of neonatal onset: a single-center retrospective study of six children. J Pediatr (1998) 1.43
Interleukin-12 receptor beta1 deficiency in a patient with abdominal tuberculosis. J Infect Dis (2001) 1.34
Study of cell wall growth in Bacillus megaterium by high-resolution autoradiography. J Bacteriol (1975) 1.33
Impaired interferon gamma-mediated immunity and susceptibility to mycobacterial infection in childhood. Pediatr Res (2001) 1.31
Invasive pulmonary infection due to Scedosporium apiospermum in two children with chronic granulomatous disease. Clin Infect Dis (1998) 1.30
Mendelian susceptibility to mycobacterial infection in man. Curr Opin Immunol (1998) 1.29
Human interferon-gamma-mediated immunity is a genetically controlled continuous trait that determines the outcome of mycobacterial invasion. Immunol Rev (2000) 1.28
Immunization with synthetic peptides containing a defined malaria epitope induces a highly diverse cytotoxic T lymphocyte response. Evidence that two peptide residues are buried in the MHC molecule. J Immunol (1992) 1.24
In a novel form of IFN-gamma receptor 1 deficiency, cell surface receptors fail to bind IFN-gamma. J Clin Invest (2000) 1.24
Morphometric and cytochemical studies of Dictyostelium discoideum in vegetative phase. Digestive system and membrane turnover. J Cell Biol (1977) 1.22
Osteopontin expression correlates with clinical outcome in patients with mycobacterial infection. Am J Pathol (2000) 1.18
Mycobacterial diseases in primary immunodeficiencies. Curr Opin Allergy Clin Immunol (2001) 1.17
Genetic predisposition to clinical tuberculosis: bridging the gap between simple and complex inheritance. Am J Hum Genet (2000) 1.17
Infections in IFNGR-1-deficient children. J Interferon Cytokine Res (1997) 1.16
Clinical consequences of defects in the IL-12-dependent interferon-gamma (IFN-gamma) pathway. Clin Exp Immunol (2000) 1.16
Listeria monocytogenes and recurrent mycobacterial infections in a child with complete interferon-gamma-receptor (IFNgammaR1) deficiency: mutational analysis and evaluation of therapeutic options. Exp Hematol (1999) 1.15
Localization of major histocompatibility complex class II molecules in phagolysosomes of murine macrophages infected with Leishmania amazonensis. Infect Immun (1991) 1.15
A causative relationship between mutant IFNgR1 alleles and impaired cellular response to IFNgamma in a compound heterozygous child. Am J Hum Genet (1998) 1.12
Exchange kinetics and composition of endocytic membranes in terms of plasma membrane constituents: a morphometric study in macrophages. Eur J Cell Biol (1987) 1.09
Endocytic membrane traffic with respect to phagosomes in macrophages infected with non-pathogenic bacteria: phagosomal membrane acquires the same composition as lysosomal membrane. Eur J Cell Biol (1988) 1.04
Pathogenic mycobacteria disrupt the macrophage actin filament network. Infect Immun (2000) 1.00
Biased amino acid distributions in regions of the T cell receptors and MHC molecules potentially involved in their association. Int Immunol (1991) 1.00
Transfer of zymosan (yeast cell walls) to the parasitophorous vacuoles of macrophages infected with Leishmania amazonensis. J Exp Med (1992) 1.00
The phagosomal environment protects virulent Mycobacterium avium from killing and destruction by clarithromycin. Infect Immun (1997) 1.00
Hematopoietic stem cell transplantation for Shwachman-Diamond syndrome: experience of the French neutropenia registry. Bone Marrow Transplant (2005) 1.00
Intramacrophage growth of Mycobacterium avium during infection of mice. Infect Immun (1991) 0.98
Disruption of the actin filament network affects delivery of endocytic contents marker to phagosomes with early endosome characteristics: the case of phagosomes with pathogenic mycobacteria. Eur J Cell Biol (2000) 0.96
Distribution of MHC class I and of MHC class II molecules in macrophages infected with Leishmania amazonensis. J Cell Sci (1994) 0.96
Exchange of material between the extracellular medium and macrophage phagosomes containing different species of bacteria including mycobacteria. Acta Leprol (1985) 0.96
Fluid phase and mannose receptor-mediated uptake of horseradish peroxidase in mouse bone marrow-derived macrophages. Biochemical and ultrastructural study. Biol Cell (1985) 0.95
Primary immunodeficiency mutation databases. Adv Genet (2001) 0.95
Mycobacterium fortuitum-chelonae complex infection in a child with complete interleukin-12 receptor beta 1 deficiency. Pediatr Infect Dis J (2001) 0.94
Molecular analysis of the LMP (latent membrane protein) oncogene in Hodgkin's disease. Leukemia (1993) 0.93
Abnormal CD40-mediated activation pathway in B lymphocytes from patients with hyper-IgM syndrome and normal CD40 ligand expression. J Immunol (1997) 0.93
Reticular dysgenesis: HLA non-identical bone marrow transplants in a series of 10 patients. Bone Marrow Transplant (2002) 0.92
Langerhans cell deficiency in reticular dysgenesis. Blood (2000) 0.92
Inheritable defects in interleukin-12- and interferon-gamma-mediated immunity and the TH1/TH2 paradigm in man. Allergy (1999) 0.91
Interferon-gamma receptor deficiency mimicking Langerhans' cell histiocytosis. J Pediatr (2001) 0.90
High levels of interferon gamma in the plasma of children with complete interferon gamma receptor deficiency. Pediatrics (2001) 0.89
Intracytoplasmic delivery of listeriolysin O by a vaccinal strain of Bacillus anthracis induces CD8-mediated protection against Listeria monocytogenes. J Immunol (1997) 0.89
Enteroviral meningoencephalitis in X-linked agammaglobulinemia: intensive immunoglobulin therapy and sequential viral detection in cerebrospinal fluid by polymerase chain reaction. Pediatr Infect Dis J (2000) 0.89
Cytochemical demonstration of alkaline phosphatase in the contractile vacuole of Dictyostelium discoideum. J Ultrastruct Res (1978) 0.88
Changes of the cell surface and of the digestive apparatus of Dictyostelium discoideum during the staruation period triggering aggregation. J Cell Biol (1977) 0.88
Recurrent Mycobacterium avium osteomyelitis associated with a novel dominant interferon gamma receptor mutation. Pediatrics (2001) 0.87
Hematopoietic stem cell transplantation in patients with severe Langerhans cell histiocytosis and hematological dysfunction: experience of the French Langerhans Cell Study Group. Bone Marrow Transplant (2003) 0.87
Regulation of myeloblastin messenger RNA expression in myeloid leukemia cells treated with all-trans retinoic acid. Blood (1993) 0.86
Extensive structural homology between H-2 K/D/L antigens and non-polymorphic class I Qa, Tla and "37" molecules suggests they may act as peptide carriers. Res Immunol (1989) 0.86
Bacille Calmette-Guérin lymphadenitis and recurrent oral candidiasis in an infant with a new mutation leading to interleukin-12 receptor beta-1 deficiency. J Investig Allergol Clin Immunol (2011) 0.86
Risk groups in patients with bladder cancer treated with radical cystectomy: statistical and clinical model improving homogeneity. J Urol (2005) 0.86
Interferon-gamma receptor deficiency: relationship between genotype, environment, and phenotype (Review). Int J Mol Med (1998) 0.86
Pineal germinoma in a child with interferon-γ receptor 1 deficiency. case report and literature review. J Clin Immunol (2014) 0.86
Genetic and molecular definition of complementation group D in MHC class II deficiency. Hum Mol Genet (1998) 0.85
Cell wall growth of Bacillus megaterium: cytoplasmic radioactivity after pulse-labeling with tritiated diaminopimelic acid. J Bacteriol (1975) 0.85
Impairment of STAT activation by IL-12 in a patient with atypical mycobacterial and staphylococcal infections. J Immunol (2000) 0.84
Genetic heterogeneity of Mendelian susceptibility to mycobacterial infection. Microbes Infect (2000) 0.84
Cellular oxidative responses and mycobacterial growth inhibition in aerosol and intradermal BCG-immunized guinea-pigs. Biologicals (1991) 0.83
Defective priming of the phagocyte oxidative burst in a child with recurrent intracellular infections. Microbes Infect (1999) 0.83
Highly diverse T cell recognition of a single Plasmodium berghei peptide presented by a series of mutant H-2Kd molecules. J Immunol (1992) 0.83
Surface expression of the IFN-gamma R2 chain is regulated by intracellular trafficking in human T lymphocytes. J Immunol (2000) 0.82
The MHC class II-restricted T cell response of C57BL/6 mice to human C-reactive protein: homology to self and the selection of T cell epitopes and T cell receptors. Mol Immunol (1997) 0.82
Wegener's autoantigen and leukemia. Blood (1991) 0.81
Real-time measurement of antigenic peptide binding to empty and preloaded single-chain major histocompatibility complex class I molecules. Eur J Immunol (1993) 0.80
Unusual intracellular trafficking of Salmonella typhimurium in human melanoma cells. Cell Microbiol (2001) 0.80
Upper urinary tract involvement in patients with bladder carcinoma in situ (Tis): its impact on management. Urology (1997) 0.80
Peptidoglycan turnover during growth recovery after chloramphenicol treatment in a Dap-Lys-mutant of Bacillus megaterium. Can J Microbiol (1980) 0.79
The diversity of antigen-specific TCR repertoires reflects the relative complexity of epitopes recognized. Hum Immunol (1997) 0.79
Binding of low concentration of peptide to H-2Kd produced in insect cells requires mouse beta 2-microglobulin co-expression. Int Immunol (1992) 0.79
A virus finds its natural killer. Nat Genet (2001) 0.79
Stem cell transplantation for immunodeficiency. Springer Semin Immunopathol (1998) 0.79
The interaction of antigenic peptides with the H-2Kd MHC class I molecule. Semin Immunol (1993) 0.79
[T-cell-depleted HLA non-identical bone marrow transplantation in the child: prevention of graft-versus-host reaction by administration of donor T lymphocytes alloreactive against the recipient]. J Soc Biol (2001) 0.79
Nonpathogenic common variants of IFNGR1 and IFNGR2 in association with total serum IgE levels. Biochem Biophys Res Commun (1999) 0.79